Japanese pharmaceutical company Kyowa Kirin will build a manufacturing facility in Lee County, according to press releases from Governor Roy Cooper and the Sanford Area Growth Alliance.

The location will be Kyowa Kirin’s first North American manufacturing operation and is expected to create 102 jobs with a $200 million tax base investment. The average wage for the jobs is $91,496. Kyowa Kirin will purchase land in the new Helix Innovation Park on Hawkins Avenue for the manufacturing facility, which is expected to be complete in four years. Kyowa Kirin’s current projects include engineering the next generation of antibodies and cell and gene therapies with the potential to help patients with high unmet medical needs, including bone/mineral, blood cancers, intractable hematologic diseases, and rare diseases.

“I am pleased to welcome Kyowa Kirin to Lee County for its next phase of growth,” Cooper said. “North Carolina’s leadership as a life sciences powerhouse for research and manufacturing aligns well with this company’s reputation for creating innovative treatments, and we believe they will find great success here.”

The announcement follows the passage of about $8.5 million in combined tax incentives for Kyowa Kirin from the Lee County Board of Commissioners and the Sanford City Council last week. At the state level, the project will be facilitated in part by a Job Development Investment Grant which makes Kyowa Kirin eligible for up to $1,611,000 in tax reimbursements over 12 years. Incentives from both state and local government only occur following performance verification by the departments of Commerce and Revenue that the company has met its incremental job creation and investment targets. Until Tuesday’s announcement, the name of the company had been a closely held secret, referred to in public meetings only as “Project BioBloom.”

“We are excited that Kyowa Kirin chose Lee County, further expanding our local life sciences industry,” said Kirk Smith, chairman of the Lee County Board of Commissioners. “We look forward to the beneficial economic impact for our community as well the future tax benefits for our citizens. The County’s investment in strategic economic development through the Sanford Area Growth Alliance continues to pay dividends.”

“Congratulations to Kyowa Kirin on the siting of their first North American biomanufacturing facility here in Sanford,” said Mayor Rebecca Wyhof Salmon. “Our City is thrilled to welcome a company so strategically focused on the manufacturing of life-saving and life-changing treatments for patients. Kyowa Kirin will be an excellent addition to our growing Life Sciences Community. We look forward to a strong and lasting relationship. We have worked hard as a City to create an environment that not only is business friendly but also a place where company team members can live, work, and flourish and this announcement validates that effort. Best wishes and a heartfelt welcome to Sanford.”

“The Sanford Area Growth Alliance enthusiastically welcomes Kyowa Kirin to the Sanford-Lee County community, where public and private sectors work together to grow and diversify the business community, increase opportunities for our workforce and improve the quality of life for our citizens,” said SAGA Chairman Jimmy Keen. “Kyowa Kirin’s decision to locate here is an endorsement of our organization’s team effort and our strong reputation at regional, state and national levels.”

“With their decision to locate at Helix Innovation Park at the Brickyard, Kyowa Kirin adds another valuable facet to Lee County’s already impressive life sciences manufacturing cluster,” said SAGA CEO Jimmy Randolph. “Their operation will complement the globally significant gene therapy manufacturing hub anchored by Pfizer, one of Lee County’s largest and longest-tenured employers, and Astellas Gene Therapies, further enhancing Sanford and Lee County’s contributions to the Research Triangle Region’s reputation as the nation’s leading biomanufacturing center.”

Because Kyowa Kirin chose a site in Lee County, classified by the state’s economic tier system as Tier 2, the company’s JDIG agreement also calls for moving $179,000 into the state’s Industrial Development Fund – Utility Account. The Utility Account helps rural communities finance necessary infrastructure upgrades to attract future business.

“Kyowa Kirin has a long and proud history of advancing novel discoveries from bench to bedside. Establishing a new center of excellence for biologics manufacturing in North America is a testament to the promising potential we see in our pipeline,” said Paul Testa, executive vice president of supply chain & manufacturing for North America. “We believe the Sanford facility will become a vital part of our global manufacturing network – helping us train employees, deliver medicines with life-changing value, and support our future growth as a region and as a global business.”